Varaha Tammisetti MD, Presenter: Nothing to Disclose

Venkateswar Rao Surabhi MD, Abstract Co-Author: Nothing to Disclose

Eduardo Jose Matta MD, Abstract Co-Author: Nothing to Disclose

Larry Allen Kramer MD, Abstract Co-Author: Nothing to Disclose

Robert J. Amato, Abstract Co-Author: Nothing to Disclose

PURPOSE OF THE EXHIBIT: 1. Discuss the various patterns of recurrences in clinical settings such as after post prostatectomy or after radiotherapy or androgen deprivation therapy and multiparametric MR (mp-MR) imaging appearances. 2. Discuss the implications of the recurrences in each setting on management. 3. Discuss and distinguish the mp-MR imaging appearances of post treatment or post surgical change from local recurrence. 3. Discuss the role of mp-MRI and it’s inclusion in the imaging strategies in each of the setting

1. Introduction - Rising PSA levels after first line treatment of prostate cancer 2. Recurrence after Radical Prostatectomy- mp-MRI imaging appearance of recurrence and expected post surgical changes 3. Recurrence after External Beam Radiotherapy - mp-MRI imaging appearance including DCE-MR and DWI, expected post treatment changes are also discussed 4. Recurrence after androgen deprivation therapy- mp-MRI imaging appearance including DCE-MR and DWI, expected post treatment changes are also discussed 5. Discuss the role of mp-MRI and imaging strategies in each of the setting

Prostate mp-MRI is useful in identifying local recurrence, post prostatectomy and after radiation failure and can help guide biopsies, assess the extent of local tumor, this information may be helpful in treatment planning.

Tammisetti, V, Surabhi, V, Matta, E, Kramer, L, Amato, R, Role of Multiparametric Prostate MRI in Recurrent Prostate Cancer.  Radiological Society of North America 2013 Scientific Assembly and Annual Meeting, December 1 - December 6, 2013 ,Chicago IL. http://archive.rsna.org/2013/13026398.html